Synergy Empire Limited Reports Revenue Growth and Strategic Changes Amid Financial Losses

Synergy Empire Limited reported its financial results for the three and nine months ended December 31, 2024, revealing a significant shift in its business operations and financial performance. The company generated revenue of $15,000 during the nine-month period, a notable change from the previous year when it reported no revenue. However, the company incurred a net loss of $63,719 for the nine months, compared to a loss of $74,261 in the same period last year. The increase in revenue was attributed to the company's transition to providing consultancy services in the food and beverage sector, following the discontinuation of its asset leasing business.

The financial statements indicate a substantial increase in general and administrative expenses, which rose to $78,719 for the nine months ended December 31, 2024, compared to $44,728 in the prior year. This increase was primarily due to higher professional fees and the write-off of bad debts, as the company faced challenges in collecting receivables. The operational changes were further underscored by the company's decision to dispose of its subsidiaries, including Synergy Empire Marshall, Lucky Star F&B Sdn. Bhd., and SH Dessert Sdn. Bhd., effective January 1, 2024. This strategic move aimed to streamline operations and reduce accumulated deficits.

In terms of organizational changes, Synergy Empire Limited appointed H’sien Loong Wong as the new President and CEO following the resignation of previous management in October 2023. The company also executed an Acquisition and Stock Purchase Agreement with Meluha Therapeutics Berhad on July 29, 2024, agreeing to acquire 10,000,000 shares of Meluha in exchange for 10,000,000 shares of its Series A preferred stock, valued at $2,155,000. This acquisition, set to be completed by March 28, 2025, marks a significant pivot towards the biopharmaceutical sector, focusing on contract manufacturing and research and development.

As of December 31, 2024, Synergy Empire Limited reported total assets of $1,795, a sharp decline from $44,914 as of March 31, 2024. The company's liabilities also decreased to $372,393 from $451,793, reflecting the impact of the divestiture of its subsidiaries. The company’s stockholders’ deficit improved slightly to $370,598 from $406,879, indicating a reduction in accumulated losses. The company’s cash position was notably low, with cash and cash equivalents reported at $0, raising concerns about its ability to sustain operations without additional funding.

Looking ahead, Synergy Empire Limited's management expressed optimism about the future, emphasizing the potential for growth in the biopharmaceutical sector following the acquisition of Meluha. However, the company acknowledged the need for additional funding to support its operations and improve profitability. The management's ability to secure financial support and effectively execute its new business strategy will be critical in determining the company's future viability, especially given its accumulated deficit of $1,022,598 as of December 31, 2024.